Menu
Latest
12 meetings · Prague, Jeju · 12–16 Oct
Reports
RAN1#126-bis · SA2#177

Glossary term · Services

WMTS

Wireless Medical Telemetry Service

Services →

WMTS is a dedicated radio service for wireless medical telemetry, allowing patient monitoring devices to transmit vital-sign data over protected spectrum, for which 3GPP specifies coexistence and operational requirements in LTE and NR bands.

Introduced
Rel-15
Where
Radio Access Network › E-UTRAN (LTE)
Specifications
2 specs
WMTS Description Purpose Specifications

Description

The Wireless Medical Telemetry Service (WMTS) is a regulatory and technical framework for radio communications used by medical telemetry equipment — devices that monitor patient vital signs such as heart rate, respiration, blood pressure, and oxygen saturation — and transmit that data wirelessly to a monitoring station. In the United States, WMTS was established by the FCC and operates in dedicated frequency bands (608–614 MHz, 1395–1400 MHz, and 1427–1432 MHz) that are reserved specifically for medical telemetry, giving these life-critical applications protection from interference by other radio services. Similar dedicated medical telemetry allocations exist in other regions, and the concept has been adopted internationally as healthcare increasingly relies on untethered patient monitoring.

Within 3GPP, WMTS appears primarily as a coexistence and spectrum-sharing consideration. Because WMTS bands are adjacent to or overlap with spectrum used by cellular systems — notably the 1400 MHz range used for LTE supplemental downlink and the 600 MHz band used for LTE and NR — 3GPP has produced technical specifications (notably 36.755 and 36.761) that define how cellular network equipment must behave to avoid harmful interference to WMTS receivers. These specifications establish coexistence requirements, protection criteria, and deployment guidance so that cellular base stations and user equipment operating in neighbouring bands do not degrade the reliability of medical telemetry links.

The technical challenge is that WMTS devices are typically low-power, battery-operated, and designed for high reliability rather than robust interference rejection. They often use narrowband or low-complexity modulation and cannot easily implement sophisticated interference mitigation. Consequently, 3GPP coexistence studies quantify the required separation distances, out-of-band emission limits, and spurious emission constraints that cellular equipment must satisfy. These requirements are captured as additional emission limits or operational restrictions in the relevant radio specifications.

In practice, WMTS coexistence requirements influence network planning for operators deploying in or near the 1400 MHz and 600 MHz bands. Operators must account for protection zones around hospitals and healthcare facilities, and equipment vendors must design filters and power amplifiers that meet the stricter emission masks. The work reflects a broader 3GPP principle: cellular systems must coexist with incumbent and mission-critical services, and coexistence requirements are developed through detailed sharing studies before new bands are standardised.

WMTS is therefore not a 3GPP-defined radio interface but a protected incumbent service whose requirements shape 3GPP specifications. Understanding WMTS is important for engineers involved in spectrum planning, RF compliance, and deployment of cellular systems in bands shared with or adjacent to medical telemetry allocations.

Purpose & Motivation

WMTS exists to guarantee reliable, interference-protected wireless communication for life-critical medical telemetry. Patient monitoring devices must transmit continuous, accurate vital-sign data; a dropped or corrupted transmission could delay clinical response. Dedicated spectrum with regulatory protection ensures these devices are not subject to the interference and congestion typical of shared industrial, scientific, and medical (ISM) bands.

The motivation for 3GPP involvement is spectrum expansion. As cellular operators sought new spectrum, particularly around 1400 MHz and 600 MHz, sharing and adjacency with WMTS bands became unavoidable. Earlier approaches lacked a systematic framework for quantifying interference from wideband cellular signals into narrowband medical telemetry receivers. 3GPP coexistence studies filled this gap by defining protection criteria and emission limits.

The result is a balanced framework: healthcare gains confidence that cellular deployments will not disrupt medical telemetry, while operators gain access to valuable spectrum with clear, standardised rules. This demonstrates how 3GPP accommodates incumbent services through rigorous sharing studies rather than simply assuming cellular priority.

Evolution Across Releases

An overview written from the defining specifications, not a verified change history. For the exact text, open the specifications listed below.

Rel-15 Initial

Initial 3GPP treatment of WMTS as an incumbent service in coexistence studies for LTE and NR bands adjacent to medical telemetry spectrum. Specifications 36.755 and 36.761 established protection criteria, emission limits, and deployment guidance to prevent harmful interference to WMTS receivers.

Defining Specifications

3GPP specifications that define or reference WMTS, with the latest known release. Sourced from the 3GPP document catalog — see methodology.

SpecificationTitleRelease
TS 36.755 vf00 US 600 MHz LTE Band 71 Technical Report Rel-15 read
TS 36.761 vf00 Extended-Band 12 Study Report Rel-15 read